Lv7
5000 积分 2023-01-09 加入
CT-121: Phase 3 Study of the Efficacy and Safety of Iptacopan (LNP023), an Oral Factor B Inhibitor, in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naïve to Complement Inhibitor Therapy
2个月前
已完结
HRS-5965, a small-molecule factor B inhibitor, in healthy participants and participants with renal insufficiency: A first-in-human, phase 1 trial
2个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
2个月前
已完结
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
2个月前
已完结
Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study
2个月前
已完结
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers
2个月前
已完结
Macrophages: Targets for next-generation cancer immunotherapy
2个月前
已完结
GPR15-guided CD8+ T regulatory cells control intestinal inflammation
2个月前
已完结
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
3个月前
已完结
Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo
3个月前
已完结
皖公网安备34019202002308
